| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $24.42 ▲ +1.33% | Yesterday | $23.97 ▼ -0.56% | Tomorrow's Ultragenyx Pharmaceutical Inc. Common Stock (RARE) setup is anchored to $24.10 and targets $24.42 (+1.33%). The near-term read is upside; watch $24.82 / $23.38 because daily realized volatility is about 6.84%. |
Tomorrow's Ultragenyx Pharmaceutical Inc. Common Stock (RARE) setup is anchored to $24.10 and targets $24.42 (+1.33%). The near-term read is upside; watch $24.82 / $23.38 because daily realized volatility is about 6.84%. | ||||
| Week | $25.09 ▲ +4.12% | Last Week | $23.68 ▼ -1.73% | The 7-day Ultragenyx Pharmaceutical Inc. Common Stock model moves from $23.68 to $25.09 (+4.12%). It gives upside momentum context for this stock, so breaks around $24.82 / $23.38 matter more than a single tick. |
The 7-day Ultragenyx Pharmaceutical Inc. Common Stock model moves from $23.68 to $25.09 (+4.12%). It gives upside momentum context for this stock, so breaks around $24.82 / $23.38 matter more than a single tick. | ||||
| Month | $26.22 ▲ +8.79% | Last Month | $23.21 ▼ -3.69% | The 1-month Ultragenyx Pharmaceutical Inc. Common Stock target is $26.22 (+8.79%), compared with the live reference near $24.10. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Ultragenyx Pharmaceutical Inc. Common Stock target is $26.22 (+8.79%), compared with the live reference near $24.10. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $27.90 ▲ +15.77% | Last Year | $22.50 ▼ -6.62% | The 1-year Ultragenyx Pharmaceutical Inc. Common Stock scenario points to $27.90 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Ultragenyx Pharmaceutical Inc. Common Stock scenario points to $27.90 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $31.85 ▲ +32.14% | 5 Years Ago | $20.85 ▼ -13.50% | The 5-year Ultragenyx Pharmaceutical Inc. Common Stock view is $31.85 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Ultragenyx Pharmaceutical Inc. Common Stock view is $31.85 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $24.10 | Mid |
| Daily Change | -3.83% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $24.10 | Daily Change | -3.83% |
| Market Cap | $2.37B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.